Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio

INTRODUCTION: Methotrexate (MTX) constitutes the first-line therapy in rheumatoid arthritis (RA), yet approximately 30% of the patients do not benefit from MTX. Recently, we reported a prognostic multivariable prediction model for insufficient clinical response to MTX at 3 months of treatment in the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Rheumatol Ther
Asıl Yazarlar: Gosselt, Helen R., Verhoeven, Maxime M. A., de Rotte, Maurits C. F. J., Pluijm, Saskia M. F., Muller, Ittai B., Jansen, Gerrit, Tekstra, Janneke, Bulatović-Ćalasan, Maja, Heil, Sandra G., Lafeber, Floris P. J. G., Hazes, Johanna M. W., de Jonge, Robert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7695780/
https://ncbi.nlm.nih.gov/pubmed/32926395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00230-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller